Your browser doesn't support javascript.
loading
Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer.
Lacouture, Mario E; Goldfarb, Shari B; Markova, Alina; Chawla, Sant P; Dewnani, Karan; Iacobucci, Marc; Lang, Julie E.
Affiliation
  • Lacouture ME; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. lacoutum@mskcc.org.
  • Goldfarb SB; Dermatology Service Department of Medicine, Memorial Sloan-Kettering Cancer Center, 530 East 74th Street, New York, NY, 10021, USA. lacoutum@mskcc.org.
  • Markova A; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Chawla SP; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Dewnani K; Sarcoma Oncology Center, Santa Monica, CA, 90403, USA.
  • Iacobucci M; NanOlogy, LLC, Fort Worth, TX, 76107, USA.
  • Lang JE; NanOlogy, LLC, Fort Worth, TX, 76107, USA.
Breast Cancer Res Treat ; 194(1): 57-64, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35471470
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Breast Neoplasms / Paclitaxel Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Breast Neoplasms / Paclitaxel Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2022 Type: Article Affiliation country: United States